GM Advisory Group’s Biostage, Inc. Common Stock BSTG Stock Holding History

GM Advisory Group’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-15,525	Closed	-$5K	–	139
2017 Q3	$5K	Hold	15,525	–	–	﹤0.01%	117
2017 Q2	$6K	Buy	15,525 +500	+3%	+$159	﹤0.01%	115
2017 Q1	$6K	Buy	+15,025	New	+$8.22K	﹤0.01%	104
2015 Q1	–	Sell	-24,525	Closed	-$78K	–	80
2014 Q4	$78K	Buy	24,525 +2,500	+11%	+$12.4K	0.04%	72
2014 Q3	$178K	Buy	22,025 +1,000	+5%	+$8.18K	0.13%	66
2014 Q2	$220K	Hold	21,025	–	–	0.19%	65
2014 Q1	$186K	Buy	+21,025	New	+$125K	0.14%	71

GM Advisory Group's BSTG Position: Q4 2017 in Review

GM Advisory Group sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 15,525 shares — an estimated $5K sold.

GM Advisory Group first reported a position in BSTG in Q1 2014 and held it in 7 quarters. The position peaked at $220K in Q2 2014. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.

GM Advisory Group reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
GM Advisory Group sold 15,525 Biostage, Inc. Common Stock shares in Q4 2017, an estimated $5K.
GM Advisory Group first reported a position in Biostage, Inc. Common Stock in Q1 2014 and held it in 7 quarters.
GM Advisory Group's Biostage, Inc. Common Stock position peaked at $220K in Q2 2014.
0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.

Based on GM Advisory Group's 13F filing for Q4 2017, filed 9 Feb 2018.